# DEFLAZACORT
> **ANDA220709** · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON PHARMA · Approved 2026-05-28
## Drug
- **FDA Application Number:** ANDA220709
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEFLAZACORT
- **Generic name:** Deflazacort
- **Active ingredients:** DEFLAZACORT
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BIOCON PHARMA
- **First approval:** 2026-05-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220709)
---
*MORVS · CC0 1.0*